Elsevier

Journal of Vascular Surgery

Volume 59, Issue 1, January 2014, Pages 220-234.e2
Journal of Vascular Surgery

Society For Vascular Surgery® document
The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: Risk stratification based on Wound, Ischemia, and foot Infection (WIfI),

https://doi.org/10.1016/j.jvs.2013.08.003Get rights and content
Under a Creative Commons license
open access

Critical limb ischemia, first defined in 1982, was intended to delineate a subgroup of patients with a threatened lower extremity primarily because of chronic ischemia. It was the intent of the original authors that patients with diabetes be excluded or analyzed separately. The Fontaine and Rutherford Systems have been used to classify risk of amputation and likelihood of benefit from revascularization by subcategorizing patients into two groups: ischemic rest pain and tissue loss. Due to demographic shifts over the last 40 years, especially a dramatic rise in the incidence of diabetes mellitus and rapidly expanding techniques of revascularization, it has become increasingly difficult to perform meaningful outcomes analysis for patients with threatened limbs using these existing classification systems. Particularly in patients with diabetes, limb threat is part of a broad disease spectrum. Perfusion is only one determinant of outcome; wound extent and the presence and severity of infection also greatly impact the threat to a limb. Therefore, the Society for Vascular Surgery Lower Extremity Guidelines Committee undertook the task of creating a new classification of the threatened lower extremity that reflects these important considerations. We term this new framework, the Society for Vascular Surgery Lower Extremity Threatened Limb Classification System. Risk stratification is based on three major factors that impact amputation risk and clinical management: Wound, Ischemia, and foot Infection (WIfI). The implementation of this classification system is intended to permit more meaningful analysis of outcomes for various forms of therapy in this challenging, but heterogeneous population.

Cited by (0)

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).

Author conflict of interest: none.

Additional material for this article may be found online at www.jvascsurg.org.

Independent peer-review and oversight has been provided by members of the SVS Document Oversight Committee (Peter Gloviczki, MD (chair), Thomas Forbes, MD, William D. Jordan Jr, MD, Glenn LaMuraglia, MD, Michel Makaroun, MD, Greg Moneta, MD, Amy Reed, MD, Russell H. Samson MD, Timur Sarac, MD, and Thomas W. Wakefield, MD).